Moreover, Nkx3.1, a prostate tumor suppressor that is frequently lost in PCa, is also a PDEF inhibitor [59], which would be more consistent with an oncogenic role for PDEF in PCa. The gene discussed is NKX3-1; the disease is prostate neoplasm.